Calling for More Research of Medication Effects in Bipolar Disorder: Response to Ketter and Dell'Osso

Affiliations

¹ From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; the Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden; and the Department of Psychiatry, Icahn School of Medicine at Mount Sinai, and the Seaver Autism Center for Research and Treatment at Mount Sinai, New York.

Comment

Mikael Landén et al. Am J Psychiatry. 2017.

. 2017 Aug 1;174(8):804-805.

doi: 10.1176/appi.ajp.2017.17050488r.

¹ From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; the Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden; and the Department of Psychiatry, Icahn School of Medicine at Mount Sinai, and the Seaver Autism Center for Research and Treatment at Mount Sinai, New York.

No abstract available

Keywords: ADHD; Attention Deficit Hyperactivity Disorder; Bipolar Disorder; Methylphenidate; Mood Disorders; Stimulants.

Comment on

The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.
Viktorin A, Rydén E, Thase ME, Chang Z, Lundholm C, D'Onofrio BM, Almqvist C, Magnusson PK, Lichtenstein P, Larsson H, Landén M. Viktorin A, et al. Am J Psychiatry. 2017 Apr 1;174(4):341-348. doi: 10.1176/appi.ajp.2016.16040467. Epub 2016 Oct 3. Am J Psychiatry. 2017. PMID: 27690517 Free PMC article.
Commentary on the Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.
Ketter TA, Dell'Osso B. Ketter TA, et al. Am J Psychiatry. 2017 Aug 1;174(8):803-804. doi: 10.1176/appi.ajp.2017.17050488. Am J Psychiatry. 2017. PMID: 28760025 No abstract available.